Cytomegalovirus Treatment Market - Industry Analysis, Market Size, Share, Trends, Application Analysis, Growth And Forecast 2021-2026

Report Code: HCR 26028 Report Format: PDF + Excel (Delivery in 48 Hrs)

Cytomegalovirus Treatment Market Overview

Cytomegalovirus Treatment Market size was valued at $503 million in 2020, growing at a CAGR of 6.0% during the forecast period 2021-2026. Cytomegalovirus (CMV) is the most commonly transmitted herpes virus which remains dormant in the human body. It is a communicable disease and it can infect people of all ages globally. Cytomegalovirus spread through direct contact with such as saliva, blood, urine, semen, and breast milk. The symptoms of Cytomegalovirus are fatigue, fever, sweats, muscle aches, sore throat, headache and others. There many medicines are available in the market for the treatment of cytomegalovirus such as ganciclovir, valganciclovir, foscarnet, cidofovir and others. Increasing prevalence of CMV retinitis and congenital CMV infection coupled with increasing public awareness related to herpes virus infections is major factor driving the growth of the market. Moreover, growing prevalence of viral infection among AIDS patients further enhance the overall market demand for Cytomegalovirus Treatment during the aforesaid period.

Report Coverage

The report: “Cytomegalovirus Treatment Market – Forecast (2021-2026)”, by IndustryARC, covers an in-depth analysis of the following segments of the Cytomegalovirus Treatment Market:
By Drugs: Ganciclovir, Valganciclovir, Foscarnet, Cidofovir, others.
By Application: Stem Cell Transplantation, Organ Transplantation, Congenital CMV Infection, other.
By Distribution Channel: Hospital pharmacies, specialty clinics, Online pharmacies, others
By Geography: North America (U.S., Canada, Mexico), Europe (Germany, U.K., France, Italy, Spain, Russia and Others), Asia Pacific (China, Japan, India, South Korea, Australia & New Zealand and Others), South America(Brazil, Argentina and others), and Rest of the World (Middle East and Africa)

Key Takeaways

  • In 2020, North America dominates the Cytomegalovirus Treatment Market owing to rising government funding and increasing research in the area.
  • Increasing innovation and development in Cytomegalovirus Treatment across the globe is driving the market growth of Cytomegalovirus Treatment. 
  • Detailed analysis of the Strength, Weakness, and opportunities of the prominent players operating in the market will be provided in the Cytomegalovirus Treatment Market report.
  • Adverse Effects and Risks Related to Cytomegalovirus Drugs are challenging the growth of the market. 

Cytomegalovirus Treatment Market Segment Analysis- By Drugs

Based on the drugs, Cytomegalovirus Treatment Market is segmented into Ganciclovir, Valganciclovir, Foscarnet, Cidofovir, others.  The Ganciclovir segment is estimated to dominate the market during the period 2021-2026. This is attributed to it is widely used as anti-viral drug to treat and prevent infections. Furthermore, Ganciclovir is most effective drug and show quick result. The Valganciclovir, segment is forecast to be the fastest-growing segment and is projected to grow at a CAGR of 5.6% during the period 2021-2026. This is mainly owing to Valganciclovir is simple and convenient and offer potential for improved patient compliance.

Cytomegalovirus Treatment Market

Cytomegalovirus Treatment Market Segment Analysis- By Application

Based on the application, Cytomegalovirus Treatment Market is segmented into Stem Cell Transplantation, Organ Transplantation, Congenital CMV Infection, other. In 2020, Stem Cell Transplantation is estimated to hold major share in the market. This is mainly rising funding from the government as well as private organization to support stem cell therapy clinical trial.  Moreover, declining prices of stem cell therapies which leads to rising preference of buyers towards cell therapy.Also, Organ Transplantation is projected to grow with a CAGR of 4.9% over the period 2021-2026. This is owing to it rising number of organ transplants across the globe.

Cytomegalovirus Treatment Market Segment Analysis- By Geography

North America dominated the Cytomegalovirus Treatment market share accounting for 40% of the market in 2020. This is mainly owing to increasing prevalence of cytomegalovirus infection in this region. According to, Centres for Disease Control and Prevention (CDC), in U.S. it is most common infection ailment cause of birth defects. 
However, the Asia-Pacific region is projected to be the fastest-growing over the period 2021-2026. This is owing to rising expenditure on healthcare coupled with rising aging population.

Cytomegalovirus Treatment Market Drivers

Increasing Prevalence of Cytomegalovirus (CMV) Infection

Increasing prevalence of cytomegalovirus (CMV) infection across the globe is driving the growth of Cytomegalovirus Treatment market. According to, Centres for Disease Control and Prevention (CDC), in U.S. one in every 150 infants are born with cytomegalovirus (CMV) infection. Moreover, increasing prevalence of viral infections among AIDS patients is also set to increase the market growth. 

Rising Number of Organ Transplantation

Rising number of organ transplantation across the globe which leads to rise in cytomegalovirus (CMV) infection among patients is also driving the market. According to, World Health Organization (WHO), around 100, 800 solid organ transplants are performed every year worldwide. Also, rising awareness about treatment of cytomegalovirus (CMV) infection among the people is also set to the growth of Cytomegalovirus Treatment Market. 

Cytomegalovirus Treatment Market Challenges 

Adverse Effects and Risks Related to cytomegalovirus drugs causes fever, rash, diarrhea, anemia, and low white blood cell and platelet counts is challenging the market. Along with this stringent regulatory process for drug approval are also further challenging the growth of the market. 

Covid-19 Impact

Moreover, the outbreak of COVID-19 around the world has impacted all industries including healthcare industry. Covid- 19 affects the Cytomegalovirus Treatment market including drastic reduction demand owing to lack of visits to healthcare facilities such as hospitals and clinics. Also owing to widespread of coronavirus it affects workforce and staffing issues, procedural prioritisation. These affects Cytomegalovirus Treatment market by cancellation of scheduled visit for primary care at hospitals and reflecting patients concern about infection.

Cytomegalovirus Treatment Market Landscape

Product launches, Merger & Acquisitions, Joint Ventures and R&D activities are key strategies adopted by players in the Cytomegalovirus Treatment Market. Cytomegalovirus Treatment top 10 companies are Chimerix, Clinigen Group PLC., F. Hoffmann-La Roche Ltd., Fresenius Kabi Canada, Genentech Inc., Gilead Sciences, Merck & Co. Inc., Mylan N.V, Teva Canada Limited, and Thermo Fisher Scientific

Acquisitions/Product Launches:

  • In January 2021, Chimerix acquired Oncoceutics, Inc. This acquisition will help chimerix to expand product portfolio. 

Relevant Reports

Report Code: HCR 0240

Report Code:  HCR 0302


For more Lifesciences and Healthcare Market reports, Please click here

Table of Contents

1.     Cytomegalovirus Treatment Market - Overview

1.1     Definitions and Scope

2.     Cytomegalovirus Treatment Market - Executive Summary

2.1     Market Revenue and Key Trends

2.2     Key trends by Drug

2.3     Key trends by Application

2.4     Key trends by Distribution Channel

2.5     Key trends by Geography

3.     Cytomegalovirus Treatment Market – Comparative Analysis

3.1     Product Benchmarking – Key Companies

3.2     Financial Analysis – Key Companies

3.3     Market Value Split by Key Companies

3.4     Patent Analysis

3.5     Pricing Analysis

4.     Cytomegalovirus Treatment Market - Startup Companies Scenario Premium

4.1     Key Startup Company Analysis by

4.1.1     Investment

4.1.2     Revenue

4.1.3     Venture Capital and Funding Scenario

5.     Cytomegalovirus Treatment Market – Industry Market Entry Scenario Premium

5.1     Regulatory Framework Overview

5.2     New Business and Ease of Doing business index

5.3     Case Studies of Successful Ventures

6.     Cytomegalovirus Treatment Market Forces

6.1     Market Drivers

6.2     Market Constraints/Challenges

6.3     Porters five force model

6.3.1     Bargaining power of suppliers

6.3.2     Bargaining powers of customers

6.3.3     Threat of new entrants

6.3.4     Rivalry among existing players

6.3.5     Threat of substitutes

7.     Cytomegalovirus Treatment Market – Strategic Analysis

7.1     Value Chain Analysis

7.2     Opportunities Analysis

7.3     Market Life Cycle

8.     Cytomegalovirus Treatment Market – By Drugs (Market Size –$Million/$Billion)

8.1  Ganciclovir

8.2  Valganciclovir

8.3  Foscarnet

8.4  Cidofovir

8.5  Others

9.     Cytomegalovirus Treatment Market - By Application (Market Size –$Million/$Billion)

9.1  Stem Cell Transplantation

9.2  Organ Transplantation

9.3  Congenital CMV Infection

9.4  Others

10.  Cytomegalovirus Treatment Market - By Distribution Channel(Market Size –$Million/$Billion

10.1 Hospital pharmacies

10.2 Specialty clinics

10.3 Online pharmacies

10.4 Others

11.  Cytomegalovirus Treatment Market - By Geography(Market Size –$Million/$Billion)

11.1 North America

11.1.1    U.S.

11.1.2    Mexico

11.1.3    Canada

11.2 Europe

11.2.1    U.K.

11.2.2    France

11.2.3    Germany

11.2.4    Italy

11.2.5    Spain

11.2.6    Russia

11.2.7    Rest of Europe

11.3 Asia Pacific

11.3.1    China

11.3.2    India

11.3.3    Japan

11.3.4    South Korea

11.3.5    Australia & New Zealand

11.3.6    Rest of APAC

11.4 South America

11.4.1    Brazil

11.4.2    Argentina

11.4.3    Others

11.5 Rest of the World

11.5.1    Middle East

11.5.2    Africa

12.  Cytomegalovirus Treatment Market - Entropy

13.  Cytomegalovirus Treatment Market – Industry/Segment Competition Landscape Premium

13.1 Market Share Analysis

13.1.1 Global Market Share – Key Companies

13.1.2 Market Share by Region – Key companies

13.1.3 Market Share by Countries – Key Companies

13.1.4 Best Practices for Companies

14.  Cytomegalovirus Treatment Market – Key Company List by Country Premium

15.  Cytomegalovirus Treatment Market Company Analysis

15.1 Company 1

15.2 Company 2

15.3 Company 3

15.4 Company 4

15.5 Company 5

15.6 Company 6

15.7 Company 7

15.8 Company 8

15.9 Company 9

15.10          Company 10

"*Financials for private companies would be provided on a best efforts basis”.

LIST OF TABLES

1.Global Competition Analysis Market 2019-2024 ($M)
2.Global Cytomegalovirus Treatment Market Analysis and Opportunity Assessment , By Drug Type Market 2019-2024 ($M)
2.1 Ganciclovir Market 2019-2024 ($M) - Global Industry Research
2.2 Valganciclovir Market 2019-2024 ($M) - Global Industry Research
2.3 Foscarnet Market 2019-2024 ($M) - Global Industry Research
2.4 Cidofovir Market 2019-2024 ($M) - Global Industry Research
3.Global Cytomegalovirus Treatment Market Analysis and Opportunity Assessment , By Distribution Channel Market 2019-2024 ($M)
3.1 Hospital pharmacies Market 2019-2024 ($M) - Global Industry Research
3.2 Retail Pharmacies Market 2019-2024 ($M) - Global Industry Research
3.3 E-commerce Market 2019-2024 ($M) - Global Industry Research
4.Global Competition Analysis Market 2019-2024 (Volume/Units)
5.Global Cytomegalovirus Treatment Market Analysis and Opportunity Assessment , By Drug Type Market 2019-2024 (Volume/Units)
5.1 Ganciclovir Market 2019-2024 (Volume/Units) - Global Industry Research
5.2 Valganciclovir Market 2019-2024 (Volume/Units) - Global Industry Research
5.3 Foscarnet Market 2019-2024 (Volume/Units) - Global Industry Research
5.4 Cidofovir Market 2019-2024 (Volume/Units) - Global Industry Research
6.Global Cytomegalovirus Treatment Market Analysis and Opportunity Assessment , By Distribution Channel Market 2019-2024 (Volume/Units)
6.1 Hospital pharmacies Market 2019-2024 (Volume/Units) - Global Industry Research
6.2 Retail Pharmacies Market 2019-2024 (Volume/Units) - Global Industry Research
6.3 E-commerce Market 2019-2024 (Volume/Units) - Global Industry Research
7.North America Competition Analysis Market 2019-2024 ($M)
8.North America Cytomegalovirus Treatment Market Analysis and Opportunity Assessment , By Drug Type Market 2019-2024 ($M)
8.1 Ganciclovir Market 2019-2024 ($M) - Regional Industry Research
8.2 Valganciclovir Market 2019-2024 ($M) - Regional Industry Research
8.3 Foscarnet Market 2019-2024 ($M) - Regional Industry Research
8.4 Cidofovir Market 2019-2024 ($M) - Regional Industry Research
9.North America Cytomegalovirus Treatment Market Analysis and Opportunity Assessment , By Distribution Channel Market 2019-2024 ($M)
9.1 Hospital pharmacies Market 2019-2024 ($M) - Regional Industry Research
9.2 Retail Pharmacies Market 2019-2024 ($M) - Regional Industry Research
9.3 E-commerce Market 2019-2024 ($M) - Regional Industry Research
10.South America Competition Analysis Market 2019-2024 ($M)
11.South America Cytomegalovirus Treatment Market Analysis and Opportunity Assessment , By Drug Type Market 2019-2024 ($M)
11.1 Ganciclovir Market 2019-2024 ($M) - Regional Industry Research
11.2 Valganciclovir Market 2019-2024 ($M) - Regional Industry Research
11.3 Foscarnet Market 2019-2024 ($M) - Regional Industry Research
11.4 Cidofovir Market 2019-2024 ($M) - Regional Industry Research
12.South America Cytomegalovirus Treatment Market Analysis and Opportunity Assessment , By Distribution Channel Market 2019-2024 ($M)
12.1 Hospital pharmacies Market 2019-2024 ($M) - Regional Industry Research
12.2 Retail Pharmacies Market 2019-2024 ($M) - Regional Industry Research
12.3 E-commerce Market 2019-2024 ($M) - Regional Industry Research
13.Europe Competition Analysis Market 2019-2024 ($M)
14.Europe Cytomegalovirus Treatment Market Analysis and Opportunity Assessment , By Drug Type Market 2019-2024 ($M)
14.1 Ganciclovir Market 2019-2024 ($M) - Regional Industry Research
14.2 Valganciclovir Market 2019-2024 ($M) - Regional Industry Research
14.3 Foscarnet Market 2019-2024 ($M) - Regional Industry Research
14.4 Cidofovir Market 2019-2024 ($M) - Regional Industry Research
15.Europe Cytomegalovirus Treatment Market Analysis and Opportunity Assessment , By Distribution Channel Market 2019-2024 ($M)
15.1 Hospital pharmacies Market 2019-2024 ($M) - Regional Industry Research
15.2 Retail Pharmacies Market 2019-2024 ($M) - Regional Industry Research
15.3 E-commerce Market 2019-2024 ($M) - Regional Industry Research
16.APAC Competition Analysis Market 2019-2024 ($M)
17.APAC Cytomegalovirus Treatment Market Analysis and Opportunity Assessment , By Drug Type Market 2019-2024 ($M)
17.1 Ganciclovir Market 2019-2024 ($M) - Regional Industry Research
17.2 Valganciclovir Market 2019-2024 ($M) - Regional Industry Research
17.3 Foscarnet Market 2019-2024 ($M) - Regional Industry Research
17.4 Cidofovir Market 2019-2024 ($M) - Regional Industry Research
18.APAC Cytomegalovirus Treatment Market Analysis and Opportunity Assessment , By Distribution Channel Market 2019-2024 ($M)
18.1 Hospital pharmacies Market 2019-2024 ($M) - Regional Industry Research
18.2 Retail Pharmacies Market 2019-2024 ($M) - Regional Industry Research
18.3 E-commerce Market 2019-2024 ($M) - Regional Industry Research
19.MENA Competition Analysis Market 2019-2024 ($M)
20.MENA Cytomegalovirus Treatment Market Analysis and Opportunity Assessment , By Drug Type Market 2019-2024 ($M)
20.1 Ganciclovir Market 2019-2024 ($M) - Regional Industry Research
20.2 Valganciclovir Market 2019-2024 ($M) - Regional Industry Research
20.3 Foscarnet Market 2019-2024 ($M) - Regional Industry Research
20.4 Cidofovir Market 2019-2024 ($M) - Regional Industry Research
21.MENA Cytomegalovirus Treatment Market Analysis and Opportunity Assessment , By Distribution Channel Market 2019-2024 ($M)
21.1 Hospital pharmacies Market 2019-2024 ($M) - Regional Industry Research
21.2 Retail Pharmacies Market 2019-2024 ($M) - Regional Industry Research
21.3 E-commerce Market 2019-2024 ($M) - Regional Industry Research

LIST OF FIGURES

1.US Cytomegalovirus Treatment Market Revenue, 2019-2024 ($M)
2.Canada Cytomegalovirus Treatment Market Revenue, 2019-2024 ($M)
3.Mexico Cytomegalovirus Treatment Market Revenue, 2019-2024 ($M)
4.Brazil Cytomegalovirus Treatment Market Revenue, 2019-2024 ($M)
5.Argentina Cytomegalovirus Treatment Market Revenue, 2019-2024 ($M)
6.Peru Cytomegalovirus Treatment Market Revenue, 2019-2024 ($M)
7.Colombia Cytomegalovirus Treatment Market Revenue, 2019-2024 ($M)
8.Chile Cytomegalovirus Treatment Market Revenue, 2019-2024 ($M)
9.Rest of South America Cytomegalovirus Treatment Market Revenue, 2019-2024 ($M)
10.UK Cytomegalovirus Treatment Market Revenue, 2019-2024 ($M)
11.Germany Cytomegalovirus Treatment Market Revenue, 2019-2024 ($M)
12.France Cytomegalovirus Treatment Market Revenue, 2019-2024 ($M)
13.Italy Cytomegalovirus Treatment Market Revenue, 2019-2024 ($M)
14.Spain Cytomegalovirus Treatment Market Revenue, 2019-2024 ($M)
15.Rest of Europe Cytomegalovirus Treatment Market Revenue, 2019-2024 ($M)
16.China Cytomegalovirus Treatment Market Revenue, 2019-2024 ($M)
17.India Cytomegalovirus Treatment Market Revenue, 2019-2024 ($M)
18.Japan Cytomegalovirus Treatment Market Revenue, 2019-2024 ($M)
19.South Korea Cytomegalovirus Treatment Market Revenue, 2019-2024 ($M)
20.South Africa Cytomegalovirus Treatment Market Revenue, 2019-2024 ($M)
21.North America Cytomegalovirus Treatment By Application
22.South America Cytomegalovirus Treatment By Application
23.Europe Cytomegalovirus Treatment By Application
24.APAC Cytomegalovirus Treatment By Application
25.MENA Cytomegalovirus Treatment By Application